• Latest Posts

Verona Pharma drug meets COPD phase 3 trial endpoints

Progress of COPD drug boosted by debt financing of up to $150M

More positive news announced for Verona’s COPD treatment

Nuance Pharma receives clearance to begin clinical trials with Ensifentrine in China

More News! 5 Aug 2019

Phase II Promise for Inhaled Chronic Lung Disease Treatment

More News! 14 Jan 2019

Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug

Update: Potential Breakthrough Treatment for Deadly Lung Disease Starts Phase IIb

UPDATE: Verona sets terms & dials back its IPO goal to a still-hefty €75M